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Upregulation of Flt3 Expression within the Bone
Marrow LinSca1c-kit Stem Cell Compartment
Is Accompanied by Loss of Self-Renewal Capacity
Mice deficient in expression of flt3 or its ligand (FL) have
reductions in B and T lymphopoiesis, with a preferential
reduction in the earliest proB cell progenitors (Macka-
rehtschian et al., 1995; McKenna et al., 2000). FL has
also been implicated to be a key and potent stimulator
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and Jacobsen, 1998) and as a consequence is frequentlyUniversity Hospital of Lund
S-221 85 Lund used to promote HSC ex vivo expansion and retroviral
mediated gene transfer (Bryder and Jacobsen, 2000;Sweden
2 The Granulocyte Research Laboratory Dao et al., 1997; Miller and Eaves, 1997; Yonemura et
al., 1997; Petzer et al., 1996; Elwood et al., 1996). Further-Rigshospitalet
University of Copenhagen more, bone marrow (BM) HSC from mice deficient in flt3
expression reveal reduced reconstitution potential in2100 Copenhagen
Denmark vivo (Mackarehtschian et al., 1995). However, whether
this reflects a role of flt3 in HSC generation or mainte-
nance during steady-state conditions or potentially in
the HSC homing, engraftment, and differentiation pro-Summary
cess following transplantation has not been established.
In the present study, we evaluated the potential role ofFlt3 has emerged as a potential regulator of hema-
topoietic stem cells (HSC). Sixty percent of cells in flt3 and its ligand in regulating HSC maintenance during
steady-state hematopoiesis by investigating the expres-the mouse marrow LinSca1c-kit HSC pool ex-
pressed flt3. Although single cell cloning showed com- sion of flt3 within the HSC compartment. Although repre-
senting only 0.1% of total BM cells, LinSca1c-kit (LSK)parable high proliferative, myeloid, B, and T cell poten-
tials of LinSca1c-kitflt3 and LinSca1c-kitflt3 cells possess virtually all long-term multilineage recon-
stituting activity in adult BM (Ikuta and Weissman, 1992;cells, only LinSca1c-kitflt3 cells supported sus-
tained multilineage reconstitution. In striking contrast, Li and Johnson, 1995; Okada et al., 1991; Orlic et al.,
1993). In agreement with others (Zeigler et al., 1994), weLinSca1c-kitflt3 cells rapidly and efficiently recon-
stituted B and T lymphopoiesis, whereas myeloid recon- found 60% of LSK cells to express detectable levels of
cell surface flt3. Although revealing a combined myeloid,stitution was exclusively short term. Unlike c-kit, activa-
tion of flt3 failed to support survival of HSC, whereas B, and T cell potential, LSKflt3 cells failed to long-term
reconstitute myelopoiesis in vivo, but rather reconstitu-only flt3 mediated survival of LinSca1c-kitflt3 recon-
stituting cells. Phenotypic and functional analysis sup- ted common lymphoid progenitors (Kondo et al., 1997)
and B and T cells. Furthermore, whereas FL (unlike KL)port that LinSca1c-kitflt3 cells are progenitors for
the common lymphoid progenitor. Thus, upregulation failed to support survival of long-term repopulating HSC
(LTRC), it efficiently supported survival of “lymphoid-of flt3 expression on LinSca1c-kit HSC cells is ac-
companied by loss of self-renewal capacity but sus- restricted” LSKflt3cells. Thus, c-kit and flt3 appear to
have distinct roles in early hematopoiesis. Whereas c-kittained lymphoid-restricted reconstitution potential.
expression in adult HSC appears crucial for normal HSC
function, upregulation of flt3 expression appears to beIntroduction
accompanied by loss of self-renewal capacity but sus-
tained lymphoid restricted reconstitution potential.All myeloid and lymphoid blood cell lineages derive from
common hematopoietic stem cells (HSC). HSC fate deci-
sions between self-renewal and commitment toward lin- Results
eage-restricted development are tightly regulated, but
the molecular mechanisms regulating these processes The LinSca1c-kit HSC Pool Consists of Flt3
remain largely unknown (Domen and Weissman, 1999). Multipotent Long-Term Repopulating Stem Cells
Most cytokines and their receptors appear to have no and Flt3 Cells with Efficient but Lymphoid-Restricted
or redundant roles in regulating the HSC pool (Metcalf, In Vivo Reconstitution Potential
1993). However, thrombopoietin (TPO) and c-kit ligand LinSca1c-kit cells contain most long-term multilin-
(KL) and their corresponding receptors c-mpl and c-kit eage reconstituting activity in murine BM (Ikuta and
have been demonstrated through gene targeting studies Weissman, 1992; Li and Johnson, 1995). However, LTRC
to be important for regulating HSC numbers and/or func- can be further enriched using additional markers such
tion (Kimura et al., 1998; Solar et al., 1998; Alexander et as Thy-1, CD34, and CD38, and the LSK population also
al., 1996; Miller et al., 1996; Geissler and Russell, 1983). contains short-term reconstituting multipotent progeni-
Like c-kit, fms-like tyrosine kinase-3 (flt3) is a cytokine tor cells (Morrison and Weissman, 1994; Osawa et al.,
tyrosine kinase receptor selectively expressed in early 1996; Randall et al., 1996; Spangrude et al., 1988). Since
stages of hematopoiesis (Lyman and Jacobsen, 1998). flt3 has been implicated to play a nonredundant role in
early hematopoietic development (Lyman and Jacobsen,
1998; Mackarehtschian et al., 1995; McKenna et al., 2000;3 Correspondence: sten.jacobsen@stemcell.lu.se
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previous studies (Zeigler et al., 1994), as much as 60%
of Lin cells expressing Sca1 and c-kit at high levels
were flt3 (frequency of LinSca1c-kitflt3 cells was
0.06% in total BM).
To obtain the LinSca1c-kitflt3 (LSKflt3) and
LinSca1c-kitflt3 (LSKflt3) candidate HSC popula-
tions (as defined by FACS analysis) at high purity, a
double sort strategy was adopted (Experimental Proce-
dures), resulting reproducibly in more than 95% purity
with regard to Sca1, c-kit, and flt3 expression (Figure
1A). LSKflt3 cells were either sorted to include the 25%
highest flt3 expressing cells or all LSKflt3 cells, re-
sulting in comparable purity (Figure 1B) and biological
data (see below).
Since flow cytometric detection of low levels of cyto-
kine receptor expression is not possible, we also applied
a highly sensitive RT-PCR method to investigate
whether FACS-purified LSKflt3 cells might express flt3
mRNA. By representing a semiquantitative RT-PCR
method, we could also get an impression about differ-
ences in flt3 mRNA expression between the sorted
LSKflt3 and LSKflt3 cells. With 10 LSKflt3 cells, we
could detect low but significant expression of flt3 mRNA
in only three out of five samples, whereas all five samples
of 10 LSKflt3 cells showed very high levels of flt3 mRNA
expression. On average, there was a 10-fold difference
in flt3 mRNA between LSKflt3and LSKflt3 cells (Figure
1C). Thus, at least a fraction of purified LSKflt3 cells
express low levels of flt3 mRNA.
LSKflt3 and LSKflt3 donor cells (Ly5.1) were trans-
planted at only 500 to 1000 cells into each lethally irradi-
ated congenic (Ly5.2) recipient along with a 200- to
300-fold excess of unfractionated (Ly5.2) BM competitor
cells. Four weeks posttransplantation, high levels of do-
nor reconstitution were observed in peripheral blood
(PB) (Figure 2A) of mice receiving LSKflt3 cells and
LSKflt3 cells (mean reconstitution of 32.5%  6.6%
and 20.1%  3.1%, respectively). However, whereas
mice transplanted with LSKflt3 cells sustained high
levels of donor reconstitution throughout the 16 weeks
of analysis (44%  15%), the level of reconstitution
contributed by LSKflt3 cells rapidly declined, although
Figure 1. Identification and Purification of LinSca1c-kitflt3 and 4.8%  1.5% donor reconstitution was maintained fol-
LinSca1c-kitflt3 Cells lowing 16 weeks (Figure 2A).
(A) Lin BM cells coexpressing Sca1 and c-kit were investigated for LSKflt3 cells supported long-term multilineage re-
expression of flt3 or stained with an irrelevant control antibody. constitution of B220 B cells (Figure 2B), CD T cells
LSKflt3 and LSKflt3 cells were sorted using the indicated sort (Figure 2C), and Gr1/Mac1 (B220CD3) myeloid cells
gates. In most experiments, the 25% highest flt3 expressing LSK
(Figure 2D). In striking contrast, LSKflt3 reconstitutioncells were sorted. However, sorting of virtually all (total) LSKflt3
of PB appeared to be almost exclusively restricted tocells was also performed, resulting in similar purity and functional
B and T cells (Figures 2B and 2C). After 4 weeks, mostdata.
(B) Reanalysis of sorted populations. FACS plots presented are all (25 of 30) mice had low levels of Gr1/Mac1 PB myeloid
in log-scale. cells, but by 12 weeks only one out of 20 mice were
(C) LSKflt3 cells and LSKflt3 cells were subjected to global mRNA positive for myeloid reconstitution (Figure 2D).
amplification. The signals for flt3 and -actin were detected by We next addressed whether the low frequency of
PhosphorImager quantitation and flt3 signals normalized against
LSKflt3 recipient mice showing long-term myeloid re-the signals of the constitutively expressed -actin gene. Results are
constitution could be due to the presence of a low fre-from analysis of five samples (mean SD) containing ten cells each.
quency of contaminating LSKflt3 HSC. One group ofSamples of 25 cells from either subset amplified without addition
of reverse transcriptase served as a negative control. mice was transplanted with 1000 LSKflt3 cells with a
purity of 97%. Since the remaining 3% of transplanted
cells were almost exclusively LSKflt3, we transplanted
Zeigler et al., 1994), adult BM cells were labeled with anti- a second group of mice with 30 LSKflt3 cells (n  5).
bodies against mature blood cell lineage markers (Lin), Notably, the mice in the two groups showed comparable
Sca1, c-kit, and flt3 to investigate flt3 expression within levels of test cell-derived reconstitution at 16 weeks
(mean of 1.6% and 1.5%, respectively). Furthermore,the LSK HSC compartment (Figure 1). In agreement with
Flt3 Stem Cells Reconstitute Lymphopoiesis
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Figure 2. In Vivo Reconstituting Ability of LinSca1c-kitflt3 and LinSca1c-kitflt3 Cells
Lethally irradiated (Ly5.2) mice were transplanted with 500–1000 LSKflt3 or LSKflt3 (Ly5.1) test cells and 150,000–200,000 congeneic (Ly5.2)
BM cells. Following 4, 8, 12, and 16 weeks, mice were investigated for percent test/donor cell contribution to total PB reconstitution.
(A) Total cell reconstitution. (B) B cell reconstitution. (C) T cell reconstitution.
(D) Myeloid reconstitution. Each time point represents the mean (SEM) from four to six experiments. Numbers above each time point indicate
frequency of positive mice.
(E) 18 weeks posttransplantation, BM cells were pooled from primary recipients of LSKflt3 and LSKflt3 cells and transplanted (1/2 femur
equivalent) into lethally irradiated secondary recipients. 6 weeks later, PB was investigated for % donor (Ly5.1) reconstitution (total and
myeloid). Data presented are means (SD) of five mice from each group.
none of the mice transplanted with 1000 LSKflt3 cells the presence of mature B220IgM B cells as well as
CD4 and CD8 single positive T cells in PB (Figure 3C).and only one out of five mice transplanted with 30
LSKflt3cells showed detectable myeloid reconstitution Notably, T cell reconstitution by LSKflt3 cells was more
rapid than that observed with the same number of(J.A. and S.J., unpublished data).
One week posttransplantation, high levels of myeloid LSKflt3 stem cells, and 4 weeks following posttrans-
plantation, the T cell chimerism was higher in mice trans-reconstitution were observed in the spleen (Figure 3A)
and BM (J.A. and S.J., unpublished data) of mice trans- planted with LSKflt3 than LSKflt3 cells (Figure 2C).
The possibility that potential LSKflt3 HSC might beplanted with 5000 LSKflt3 cells. However, similarly to
PB, myeloid reconstitution in BM and spleen dropped negatively affected in their reconstitution potential by
the flt3 antibody was addressed by injecting 1000 LSKbelow detection level following 6 weeks (Figure 3B).
Furthermore, LSKflt3 cells failed to multilineage recon- (Ly5.1) cells which had been incubated either with the
flt3 antibody or with an isotype-matched control anti-stitute secondary recipients, whereas LSKflt3 cells sus-
tained high levels of multilineage reconstitution upon serial body. The level of reconstitution and lineage distribution
was comparable in the two groups, demonstrating thattransplantation (Figure 2E). LSKflt3-derived lymphoid
cells differentiated normally as demonstrated through the flt3 antibody has little or no effect on HSC reconstitu-
Immunity
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Table 1. HSC Reconstitution Potential Is Not Affected
by an Anti-flt3 Antibody
4 Weeks 8 Weeks
% Donor Reconstitution % Donor Reconstitution
Cells Antibody Total Myeloid Total Myeloid
LSK flt3 24(2) 5(2) 33(4) 5(3)
LSK control 23(9) 4(1) 32(6) 6(5)
1000 freshly isolated LinSca1c-kit (Ly5.1) cells were incubated
with the anti-flt3 antibody (as in the purification experiments) or
with an isotype control antibody and then transplanted directly to
irradiated (Ly5.2) recipients with 200,000 unfractionated congeneic
(Ly5.2) BM cells. Peripheral blood was analyzed at the indicated
time points for presence of donor (Ly5.1)-derived reconstitution.
Mean data (SD) from one out of two representative experiments.
LSKflt3 cells having a myeloid differentiation potential,
as demonstrated for the recently identified common
lymphoid progenitor (CLP) (Kondo et al., 1997). Thus,
clonal in vitro and in vivo assays were employed next
to investigate the myeloid and lymphoid differentiation
potential of single LSKflt3 cells.
Most if not all LSKflt3 as well as LSKflt3 cells (98%
and 97%, respectively) proliferated in response to a de-
fined cocktail of cytokines, and a very high proliferative
potential was revealed for both populations (Figure 4A).
Morphological evaluation revealed that virtually all
LSKflt3- and LSKflt3-derived clones produced granu-
locytes as well as macrophages (Figure 4B). In the same
experiments, using a recently developed in vitro assay
for proB cell development (Veiby et al., 1997), as much
as 60% of LSKflt3 cells revealed an in vitro B cell
Figure 3. In Vivo Short-Term Multilineage Reconstituting Ability of
differentiation potential (Figure 4C). These data demon-LinSca1c-kitflt3 and LinSca1c-kitflt3 Cells
strated that virtually all in vitro clonogenic LSKflt3 cells(A) Short-term myeloid engraftment in spleen from (Ly5.1) donor
(as LSKflt3 stem cells) have a myeloid differentiationLSKflt3 (left panel) and LSKflt3 (right panel) cells 1 week following
potential and that most of these also have a B cell poten-transplantation of 1000–5000 cells into Ly5.2 recipients without
competition. Plots show myeloid versus lymphoid engraftment of tial. However, to unequivocally demonstrate the existence
gated Ly5.1 cells. Similar data were observed in BM (not shown) of LSKflt3 progenitor cells with a combined myeloid,
after 1 week. B, and T cell differentiation potential, it was paramount
(B) May-Gru¨nwald/Giemsa-stained donor (Ly5.1GR1/MAC1)-de-
to also demonstrate the development of B and T cellsrived cells from LSKflt3 (left panels) and LSKflt3 (right panels) cells
from single clonogenic cells. Toward this aim, intrathymicfrom BM (upper panels) and PB (lower panels) 6 weeks following
(i.t.) injections were employed, since T cell precursortransplantation (from one representative experiment out of four to-
tal). A 10 m scale is inserted on the right side of each photo. homing and reconstitution can be rather inefficient fol-
(C) Donor-derived mature B and T cells 6 weeks following trans- lowing i.v. injections (Goldschneider et al., 1986). Single
plantation of LSKflt3 cells. Plots show expression of B220 versus LSKflt3 progenitors were individually plated and cul-
IgM (left panel) and CD8 versus CD4 (right panel) on Ly5.1 gated
tured in KLFLIL-7 for 11–13 days, at which time halfcells.
the content of the resulting clones were individually
picked and transplanted i.t. in sublethally irradiated
mice, whereas the other halves were cultured for pro-
longed time for detection of B cell potential in vitro. Ation potential (Table 1). Thus, whereas LSKflt3 HSC
support long-term multilineage reconstitution, LSKflt3 total of 18 mice were i.t. injected with single colonies,
of which eight revealed development of flt3-derivedcells rapidly and efficiently reconstitute B and T lympho-
poiesis but fail to long-term reconstitute myelopoiesis. T cells (Figure 4D). All 18 colonies also generated
B220CD19 B cells in vitro (data not shown), and the
T cell reconstituted thymi also demonstrated presenceMyeloid and Lymphoid Differentiation Potential
of Single LinSca1c-kitflt3 Cells of low numbers of B220IgM B cells (Figure 4D).
LSKflt3 (as well as LSKflt3) cells also efficiently recon-The limited ability of LSKflt3 cells to in vivo reconstitute
myelopoiesis might reflect that upregulation of flt3 ex- stituted CD3NK1.1 NK cells (Figure 4E). Thus, al-
though LSKflt3 cells fail to long-term reconstitute my-pression within the LSK HSC compartment is accompa-
nied by loss of self-renewal capacity. Alternatively, it elopoiesis in vivo, they possess a common myeloid,
NK-, B, and T cell differentiation potential.might be a consequence of only a small fraction of single
Flt3 Stem Cells Reconstitute Lymphopoiesis
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Figure 4. Lineage Potential of LinSca1c-kitflt3 and LinSca1c-kitflt3 Cells
Single LSKflt3 and LSKflt3 cells were seeded directly (either by a single cell depositor coupled to FACSVantage or manually, resulting in
similar results) into medium supplemented with different cytokine combinations and evaluated for clonogenic growth and differentiation
potential.
(A) Cloning frequency (white bars) and clone size (black bars represent percent of clones covering 50% of the well) were evaluated 10 days
after initiation of cultures supplemented with KL, FL, MGDF, IL-3, G-CSF, and CSF-1. Results represent the mean (SEM) of three individual
experiments.
(B) Contents of individual wells were transferred to glass slides, May-Gru¨nwald/Giemsa-stained, and evaluated for the presence of macrophages
and granulocytes. Results represent the means (SD) of two individual experiments.
(C) ProB cell potential of LSKflt3 cells evaluated by plating cells at a density of one cell per well in a serum-depleted medium supplemented
with KL, FL, and IL-7. 14–28 days after initiation of culture, individual colonies were picked and analyzed by flow cytometry to verify the
presence of proB cells, as defined by combined B220 and CD19 expression. Results represent the mean (SEM) of three individual experiments
and are presented as percent LSKflt3 cells forming proB cell colonies. LSKflt3 cells, although having a high B cell reconstitution potential,
do not form proB cells in response to FL, KL, and IL-7 in this assay (Borge et al., 1999), probably due to the lack of flt3 receptor expression,
and were therefore not investigated for in vitro proB cell formation in the present study.
(D) Cells were individually deposited and cultured for 11–13 days in a medium supplemented with KL, FL, and IL-7 before half the content of
individual colonies were picked and injected intrathymically in congenic (Ly5.2) mice, whereas the other halves were individually analyzed for
in vitro proB cell generation 6–8 days later by flow cytometry. Thymi were analyzed 20 days after transplantation for donor (Ly5.1)-derived
cells. LSKflt3-derived thymocytes stained with CD4 and CD8 (left panel) and with B220 and IgM in a representative mouse (right panel). All
clones transplanted intrathymically produced B220CD19 proB cells in vitro (data not shown).
(E) 3 weeks after transplantation of 2000–5000 LSKflt3 or LSKflt3 (Ly5.1) cells to lethally irradiated mice, spleens were analyzed for presence
of CD3NK1.1 NK cells. Percentages in quadrants represent means of three mice from two individual experiments.
Flt3 Ligand but Not c-kit Ligand Promotes Survival promote survival of LTRC and LSKflt3 reconstituting
cells, respectively.of LinSca1c-kit Cells with a Lymphoid-Restricted
In Vivo Reconstitution Potential
Next, we investigated whether the LSK HSC compart- Relationship between LinSca1c-kitflt3 Cells,
LinSca1c-kitflt3 Long-Term Repopulating Stemment might contain FL-responsive LTRC with undetect-
able levels of cell surface flt3 expression, utilizing the Cells, and Common Lymphoid Progenitor Cells
Previous studies demonstrated that LTRC in adult miceobservation that FL similar to KL (as single cytokines)
has a strong viability promoting effect on targeted primi- are almost exclusively CD34 (Osawa et al., 1996; Sato
et al., 1999). LSKflt3 adult BM cells were found to betive progenitors (Bodine et al., 1992; Veiby et al., 1996).
In agreement with previous studies (Bodine et al., 1992; almost exclusively CD34, whereas LSKflt3 cells as
expected contained a small but significant (5%) fractionKeller et al., 1995; Li and Johnson, 1994), KL efficiently
supported in vitro survival of LSK long-term repopulat- of CD34 cells (Figure 5A).
A CLP with potent but lymphoid-restricted reconstitu-ing HSC, whereas FL failed to support maintenance of
LSK cells capable of long-term myeloid reconstitution tion potential was recently identified (Kondo et al., 1997).
Although also “lymphoid-restricted” in their in vivo re-(Table 2). Notably, although LSKflt3 cells express high
levels of both c-kit and flt3 (Figure 1), FL but not KL constitution potential (Figure 2A), the in vitro myeloid
potential of LSKflt3 cells (Figure 4B) suggested thatpromoted in vitro survival of reconstituting LSKflt3 cells
(Table 2). Thus, KL and FL possess distinct abilities to the LSKflt3 population is distinct and most likely an
Immunity
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Table 2. Distinct Abilities of KL and FL to Promote Survival of Long-Term Reconstituting Stem Cells and LinSca1c-kitflt3
Reconstituting Cells
Donor-Derived Reconsitution
4 Weeks 6–8 Weeks 22 Weeks
Cells Treatment % Total Myeloid % Total Myeloid % Total Myeloid
LSK Uncultured ND 29(4) 7/7 25(22) 4/5
LSK Medium ND 0(0) 0/5 2(4) 1/5
LSK KL ND 30(15) 12/12 20(22) 4/5
LSK FL ND 4(2) 2/13 1(1) 0/5
LSKflt3 Uncultured 20(8) 6/10 12(2) 3/10 ND
LSKflt3 Medium 0(0) 0/3 0(0) 0/3 ND
LSKflt3 KL 0(0) 0/9 1(3) 1/9 ND
LSKflt3 FL 19(10) 16/18 12(6) 6/17a ND
1000 freshly isolated LinSca1c-kit or LinSca1c-kitflt3 (Ly5.1) cells were transplanted intravenously to irradiated (Ly5.2) recipients
either directly (uncultured) or after 4–7 days incubation in serum-free medium in the absence (medium only) or presence of KL or FL (50 ng/
ml) each. 200,000 unfractioned congenic (Ly5.2) BM cells were cotransplanted to provide a competitor and survival population. Peripheral
blood was analyzed at the indicated time points (LinSca1c-kitflt3 recipients were only analyzed at 4 and 6 weeks) for presence of donor
(Ly5.1)-derived multilineage reconstitution. Mean data (SD) from three experiments.
a Three mice in this group had a myeloid reconstitution just above detection level (0.1%).
intermediate between LTRC and CLP. In agreement with HSC in mice (Matthews et al., 1991) and has since
emerged as a likely regulator of the HSC pool in micethis, the lymphoid reconstitution potential of 1000
and human (reviewed in Lyman and Jacobsen, 1998).LSKflt3 cells (in competition with 200,000 BM cells)
Of particular relevance, BM from mice deficient in flt3was considerably higher than that of the same number
expression have reduced ability to multilineage reconsti-of CLP (contribution to total PB cellularity of 20%  3%
tute lethally irradiated recipients (Mackarehtschian etand 3.5% 1.7%, respectively, at 4–5 weeks posttrans-
al., 1995). However, such findings are not necessarily aplantation; mean of two experiments  SD, n  10).
consequence of reduced HSC numbers in steady-stateFurthermore, whereas the CLP express low levels of
BM and could rather reflect an important (direct or indi-Sca1, c-kit, and the IL-7R (Figure 5B and Kondo et al.,
rect) role of flt3 and its ligand in the process of homing,1997), LSKflt3 cells, like LTRC, express high levels of
reconstitution, or differentiation of HSC following trans-Sca1 and c-kit, but lack detectable IL-7R expression
plantation.(Figure 5B).
Single cell clonogenic assays revealed that LSKflt3To unequivocally demonstrate the hierarchical relation-
and LSKflt3 cells both have a high in vitro proliferativeship between LSKflt3 HSC and LSKflt3 reconstituting
capacity and a combined myeloid, B, and T cell differen-cells, LSKflt3 and LSKflt3 (Ly5.1) cells were trans-
tiation potential, supporting their primitive nature. Further-planted in competition with 200,000 unfractionated BM
more, as few as 500–1000 LSKflt3 cells were capable of(Ly5.2) and analyzed 18 weeks posttransplantation.
efficiently reconstituting lethally irradiated recipients inWhereas LSKflt3 HSC as expected generated LSKflt3
vivo when competing with a 200- to 300-fold excess ofas well as LSKflt3 cells (Figure 5C), LSKflt3 cells failed
unfractionated BM cells. However, surprisingly, and un-to sustain LSK cells over time (Figure 5C). However, both
like LSKflt3 HSC, LSKflt3 reconstituting cells failed toLSKflt3 and LSKflt3 cells produced cells with a CLP
fulfill other key characteristics of self-renewing HSC.phenotype (LinScalowc-kitlowIL-7R; Figure 5D), sup-
First, although significant levels of reconstitution wereporting the idea that LSKflt3 reconstituting cells repre-
observed in the long-term with LSKflt3cells, their contri-sent an intermediate between LSKflt3 HSC and CLP.
bution was steadily declining, in contrast to the sustainedWe have previously shown that FL in vitro promotes
reconstitution activity of LSKflt3 HSC. Furthermore, al-the lymphoid commitment process from LSKflt3 cells
though having an in vitro myeloid differentiation poten-and induction of IL-7R expression (Borge et al., 1999).
tial, in vivo myeloid reconstitution by LSKflt3 cells wasHere, FLIL-7 stimulation in vitro resulted in formation
almost exclusively short term, and experiments sug-of cells with a CLP phenotype (Figure 5E). Furthermore,
gested that the low frequency (4%–5%) of mice withwhen donor-derived LinScalowc-kitlowIL-7R cells were
long-term myeloid reconstitution could be due to infre-sorted from mice transplanted with LSKflt3 cells, they
quent but contaminating LSKflt3 cells in the sortedproduced large numbers of B220 cells (99%) in re-
LSKflt3 population.sponse to FL, KL, and IL-7, whereas only 1% of the cells
Although a previous study concluded that flt3 is ex-produced colonies in response to a cocktail of myeloid
pressed on a fraction of LTRC in murine BM (Zeigler etgrowth factors (IL-3, Tpo, G-SCF, and GM-CSF; J.A. and
al., 1994), all LinSca1flt3 BM cells were, as in theS.J., unpublished data).
present study, found to coexpress CD34, and more im-
portantly, a drop in reconstitution activity was observed
Discussion with time. That flt3 might not be expressed on LTRC
is also supported by recent experiments showing that
The flt3 receptor was originally identified and character- FL-deficient mice have normal levels of BM LTRC (E.S.
and S.J., unpublished data).ized based on its preferential expression on candidate
Flt3 Stem Cells Reconstitute Lymphopoiesis
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Figure 5. Coexpression Pattern of CD34 and IL-7R on LinSca1c-kitflt3 Cells and Relationship to CLP
(A) Lin-depleted BM cells stained for Sca1, c-kit, and flt3 expression together with anti-CD34.
(B) BM cells stained with anti-lineage cocktail together with anti-Sca1, c-kit, and IL-7R. 7AAD was included to exclude dead cells. Note that
quadrant I is where LSKflt3 cells reside, whereas quadrant III is where the LinSca1loc-kitloIL-7R CLP population resides (Kondo et al., 1997).
Also note that virtually no LSK(flt3) cells express IL-7R (quadrant II).
(C) 1000 LSKflt3 and LSKflt3 (Ly5.1) cells were injected into lethally irradiated Ly5.2 recipients. After 18 weeks, BM cells were investigated
for donor-derived LSKflt3 and LSKflt3 cells.
(D) 5000 LSKflt3 and LSKflt3 (Ly5.1) cells were injected into lethally irradiated Ly5.2 recipients. After 3 weeks, spleens were investigated
for donor derived CLP. Boxes identify position of the CLP and represent means of three mice from two individual experiments.
(E) LSKflt3 cells were cultured in vitro for 7 days in FL  IL-7 and subsequently investigated for presence of cells with a CLP phenotype.
Representative analysis from one of two independent experiments.
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Although the highly purified LSKflt3 population con- man HSC assays, since it is not established how effi-
tains at least some cells expressing low levels of flt3 ciently these surrogate assays can distinguish between
mRNA, our data clearly demonstrate that the 60% of short- and long-term reconstituting human HSC. How-
cells within the BM LSK compartment expressing de- ever, most data would suggest a key role of flt3 in human
tectable cell surface flt3 is functionally distinct from that HSC, although the status of flt3 expression and function
of LSKflt3 LTRC, and that LSKflt3 cells have a promi- on human LTRC remains to be explored in more detail.
nent but lymphoid-restricted reconstitution potential. There are also multiple lines of data suggesting that flt3
The ability of the LSKflt3 population to reconstitute and its ligand might be involved in regulating murine
lymphopoiesis is clearly superior to that of the CLP pop- LTRC numbers or function under conditions other than
ulation (Kondo et al., 1997), and the LSKflt3 cell popula- steady-state hematopoiesis. Although the mechanisms
tion provides a more rapid lymphoid reconstitution than remain unclear, this possibility is supported by reconsti-
the LSKflt3 population. Thus, LSKflt3 cells could po- tution studies with flt3-deficient BM (Mackarehtschian
tentially be used to rapidly and efficiently correct defi- et al., 1995) and by studies showing that FL can syner-
ciencies in lymphopoiesis in immunocompromised re- gize with other early acting cytokines to preserve HSC
cipients. isolated from 5-fluorouracil-treated mice (Matsunaga et
Both KL and FL do, as single cytokines, effectively al., 1998), suggesting that flt3 might perhaps be upregu-
promote in vitro survival of primitive hematopoietic pro- lated on cycling HSC.
genitors (Bodine et al., 1992; Keller et al., 1995; Veiby
et al., 1996). Whereas we confirmed the ability of KL to Experimental Procedures
promote survival of LTRC within the LSK pool, FL failed
Hematopoietic Growth Factorsto have any such effect, in agreement with the absence
Recombinant human (rh) IL-7 was generously provided by Dr. Na-of detectable flt3 cell surface expression on LTRC. In
talio Vita, Sanofi Elf (Montpellier, France). Rh megakaryocyte growthstriking contrast, FL efficiently supported survival of
and development factor (MGDF), rh granulocyte colony-stimulatingLSKflt3 reconstituting cells, whereas KL had no effect,
factor (G-CSF), and recombinant mouse (rm) granulocyte-macro-
although LSKflt3 and LSKflt3 cells expressed high phage colony-stimulating factor (GM-CSF) were generously pro-
and comparable levels of c-kit. As we have reported vided by Amgen Corp. (Thousand Oaks, CA). Rm mast cell growth
before (Borge et al., 1999), FL has no viability promoting factor (C-kit ligand; KL) and rh fms-like tyrosine kinase-3 ligand
(Flt3L; FL) were kind gifts from Immunex (Seattle) and Rh interleukin-effect on LSKflt3 cells. The lack of KL responsiveness
11 (IL-11) from Genetics Institute (Cambridge, CA). Rh colony-stimu-of LSKflt3 cells is not restricted to effects on survival,
lating factor 1 (CSF-1) was from Chiron (Emeryville, CA), and Rmsince KL also has little or no ability to synergistically
interleukin-3 (IL-3) from PeproTech Inc. (Rocky Hill, NJ). Cytokines
interact with other cytokines to stimulate growth of were used at predetermined optimal concentrations, and all human
LSKflt3 cells (J.A. and S.J., unpublished data). These cytokines utilized have been shown to be fully crossreactive with
findings suggest that the distinct abilities of FL and KL murine cells.
to promote early lymphoid and myeloid development,
respectively (Borge et al., 1999; Lyman and Jacobsen, Enrichment and Purification of Subpopulations of LinSca1 BM
1998), cannot solely be explained by different expres- Cells Based on Expression of c-kit and Flt3
All sorts were performed by an immunomagnetic-based preenrich-sion patterns for flt3 and c-kit and could potentially
ment followed by multicolor flow cytometric sorting. In brief, lineage-result from utilization of different signaling pathways as
depleted (Lin/lo) BM cells were isolated from 5- to 18-week-oldindicated in recent studies (Zhang et al., 2000).
C57Bl/6 (Ly5.2) from M&B (Ry, Denmark) or offspring of congenicThe observation that transplanted LSKflt3 cells effi-
(Ly5.1) breeders originating from Jackson Laboratories (Bar Har-
ciently regenerated LSKflt3 cells in vivo but not vice bor, ME). BM cells were incubated at 4	C for 30 min in a cocktail
versa confirms the hierarchical relationship between of predetermined optimal concentrations of antibodies: purified
these two populations in the LSK HSC pool. Further- RA3-6B2 (B220), RB6-8C5 (Gr1), M1/70 (Mac1), 53-6.7 (CD8), 53-7
(CD5), H129.19 (CD4), and Ter-119, all from PharMingen (San Diego,more, the higher reconstitution potential as well as lack
CA). Cells were incubated at 250 
 106 cells/ml with sheep anti-ratof IL-7R expression of LSKflt3 cells clearly implicate
IgG (Fc)-conjugated immunomagnetic beads (Dynal, Oslo, Norway)the CLP as progeny of LSKflt3 cells, a conclusion sup-
at a cell:bead ratio of 1:0.3, at 4	C for 45 min. Magnetic beads wereported by the formation of CLP (LinScalowc-kitlowIL-7R) removed with a magnetic particle concentrator (MPC-6, Dynal), and
from LSKflt3 cells in vitro as well as in vivo. Thus, unattached cells were exposed to the same absolute amount of
upregulation of flt3 expression within the BM HSC pool magnetic beads and processed as for the first separation.
is coupled to loss of self-renewal ability and lymphoid- Lin/lo cells recovered from the supernatant were further purified
based on the expression of Lineage, Sca1, c-kit (Bryder and Jacob-restricted repopulating ability.
sen, 2000; Li and Johnson, 1995), as well as flt3. In brief, Lin/lo cellsWhat implications, if any, do these findings have for
were resuspended at 100–400 
 106 cells/ml and incubated for 15the recent and considerable interest in utilizing FL to
min on ice with CyChrome-conjugated goat anti-rat antibody (Caltag
promote retroviral-mediated gene transfer and expan- Laboratories, Burlingame, CA) and subsequently stained with Fitc-
sion of reconstituting candidate human HSC (reviewed conjugated rat anti-mouse E13-161.7 antibody (Sca1), APC-conju-
in Lyman and Jacobsen, 1998; Petzer et al., 1996; Piaci- gated rat anti-mouse 2B8 (c-kit), and PE- or biotin-conjugated rat
bello et al., 1997, Dao et al., 1997)? As a consequence anti-mouse flt3 (A2F10.1) plus streptavidin-PE or isotype-matched
control antibodies (all PharMingen). Cells were stained with 7-aminoof promising preclinical results in these directions, FL
actinomycin (7-AAD; Sigma-Aldrich Co, St. Louis, MO) to excludehas surfaced as one of the key stimulators of candidate
dead cells and LinSca1c-kit (LSK) cells were sorted on a FACS-human HSC, and there are a number of other findings
Vantage Cell Sorter (Becton Dickinson, San Jose, CA), equipped
suggesting that c-kit and flt3 might have different func- with an 488 nm argon and a 633 nm He-Ne laser, at a rate of 2000–
tions in murine and human HSC. However, it is possible 8000 cells per second. The purity was high after the first sort (95%
that a human counterpart of the LSKflt3 reconstituting with regard to Lin, Sca1, and c-kit expression). LSK cells were in a
second sorting separated into flt3 and flt3 populations. The sortedcells presented here could reconstitute in surrogate hu-
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LSKflt3 subfraction was 95%–99% pure when reanalyzed on a ile food and autoclaved acidified water. Irradiated C57Bl/6 mice
(three to five mice per group and experiment) were cotransplantedFACS Vantage or FACSCalibur (Becton Dickinson).
with 150,000–200,000 unfractionated congeneic (Ly5.2) BM cells to
provide a competitor and survival population. Peripheral blood (PB)Detection of Flt3 Transcripts in LinSca1c-kitflt3
samples were obtained at different time points. To study short-termand LinSca1c-kitflt3 Cells
(1–2 weeks) reconstitution, Ly5.1 LSKflt3 and LSKflt3 cells wereFor semiquantitative detection of flt3 transcripts, LSKflt3 cells and
injected without competition into lethally irradiated Ly5.2 recipients,LSKflt3 cells were subjected to global mRNA amplification and
and spleen and BM were investigated for Ly5.1 and lineage reconsti-subsequent Southern analysis essentially as described previously
tution. Donor Ly5.1 cells were also sorted for morphological evalua-(Theilgaard-Mo¨nch et al., 2001; Brady et al., 1990). In brief, cells were
tion. In some experiments, Ly5.1 donor cells were injected directlytransferred into PCR tubes using an automated micromanipulator
into the thymus of 4- to 8-week-old C57Bl/6 (Ly5.2) mice 2–6 hrdevice. Subsequently, cells were lysed in first strand buffer followed
after sublethal irradiation (650 rad) as previously describedby reverse transcription of mRNA using an oligo(dT)-primer. In a
(Goldschneider et al., 1986), and the thymi were isolated and ana-second step, the first strand cDNA was polyadenylated by terminal
lyzed 20 days later. Serial transplantations were performed by pool-transferase to generate a 5-oligo(dT)-transcript-poly(A)-3 cDNA
ing BM from eight primary recipients 18 weeks posttransplantationthat finally was amplified by PCR using a sequence independent
and injecting 1/2 femur equivalent into secondary irradiated (Ly5.2)X-(dT)24 primer. The resulting cDNA (2 g) was run on a 1% agarose
recipients. Cells from all in vivo assays were stained with antibodiesgel, transferred to a nylon membrane by capillary blotting, and fixed
against Ly5.1 and Ly5.2, as well as lineage markers (CD3, CD4,by UV irradiation. Probes used for Southern hybridization were generat-
CD8a, B220, IgM, Mac1, Gr1, and NK1.1; all from PharMingen), andedby PCR from sequence-verified clones containing the 3 end of the
subsequently analyzed on a FACSCalibur or sorted on a FACSVan-flt3 and -actin mRNA sequence. The flt3 clone was established
tage. As adopted in other studies (Domen et al., 2000; Hsu et al.,from LSKflt3 cells by PCR and inserted into the pCRII vector ac-
2000; Morrison and Weissman, 1994), mice were considered ascording to the manufacturer (InVitrogen, Carlsbad, CA). The follow-
donor/test cell reconstituted if more than 0.5% of PB cells were ofing primers were used for flt3 cloning and probe synthesis: forward
donor origin, and positive for myeloid reconstitution if Gr1/Mac1primer 5-AGAAGTTAGCGAGGAGGCC-3, reverse primer 5-ATT
cells represented at least 0.1% of the reconstitution.TCCATCCATAAAATATATCAC-3. The cytoskeletal -actin IMAGE
clone (3377012) was obtained from the HGMP Resource center
(Cambridge, UK). The following primers were used for cytoskeletal Phenotypic Analysis of the Lin/loSca1c-kit HSC Compartment
Lineage-depleted BM cells were stained with anti-Sca1-biotin (de--actin probe synthesis: forward primer 5-TTGCTTCTGTGTAAAT
TATGTAC-3, reverse primer 5-GTAAGGTGTGCACTTTTATTGG-3. tected with Streptavidin-CyChrome) anti-c-kit-APC, anti-flt3-PE in
combination with anti-CD34-Fitc (all from Pharmingen). To studyProbes (50 ng) were radiolabeled with 32P-dCTP (Random Primers
DNA labeling system, GIBCO BRL, Life Technologies, Paisley, UK), IL-7R expression on Lin/loSca1c-kit cells, the same cocktail of
purified antilineage antibodies was used as for lin depletion (visual-purified (QIAaquick Nucleotide removal c-kit, Quiagen, Hilden, Ger-
many), and hybridized at 65	C overnight in a 5 
 SSPE buffer (5 
 ized by CyChrome-conjugated goat anti-rat antibody), together with
directly conjugated anti-B220-CyChrome, anti-CD3-CyChrome,Denhardt’s  0.1% bovine serum albumin, 0.1% Ficoll 400, 0.1%
Polyvinylpyrolidon MW 40.000; 5 
 SSPE  0.9 M NaCl, 0.05 M anti-Sca1-Fitc, anti-c-kit-APC, and anti-IL-7R-Biotin (A7R34; gen-
erously provided by Dr. Koichi Akashi; visualized by Streptavidin-NaH2PO4·H2O, and 5 mM EDTA [pH 7.7]; all reagents from Sigma,
St. Louis, MO). Following hybridization, membranes were washed PE) antibodies. 7-AAD was included to exclude dead cells. Stained
BM cells were analyzed on a FACSCalibur.2 
 15 min at 62	C in 2 
 standard saline citrate (1 
 SSC  150
mM NaCl and 15 mM sodium citrate [pH 7]), 0.1% SDS followed
by 2 
 15 min in 0.2 
 SSC, 0.1% SDS. Blots were analyzed by Reconstitution of CLP in Spleen and BM of Mice Transplanted
PhosphorImager quantitation (Fuji Imaging Plate, Fuji Imaging Ana- with LinSca1c-kitflt3 and LinSca1c-kitflt3 Cells
lyzer BAS-2500, Image Reader V1.4E and Image Gauge V.3.01 soft- LSKflt3 and LSKflt3 (Ly5.1) cells were injected into lethally irradi-
ware, Fuji Photo Film Europe, Duesseldorf, Germany). Signals for ated Ly5.2 recipients with 200,000 unfractionated BM cells of recipi-
flt3 and-actin expression were corrected by subtracting the signals ent type to investigate their ability to generate LSKflt3 and LSKflt3
from the negative control, i.e., cells amplified without addition of cells in vivo. BM cells were stained with antibodies against lineage
reverse transcriptase. The corrected flt3 signals were normalized (visualized by a CyChrome-conjugated goat anti-rat antibody),
against the corrected -actin signals to compare the expression Ly5.2-Cy5-PE, Sca1-Fitc, c-kit-APC, and flt3-biotin (visualized by
levels of flt3 transcripts in LSKflt3 cells and LSKflt3 cells. Streptavidin-PE). To study the generation of CLP, spleen cells were
incubated with antibodies against lineage (visualized by CyChrome-
goat-anti-rat antibody), Ly5.2-Cy5-PE, Sca1-Fitc, c-kit-APC, andSingle Cell Cultures
LSKflt3 and LSKflt3 cells were seeded in Terasaki plates at a IL-7Rbiotin (visualized by Streptavidin-PE). 7-AAD was included
in all samples to exclude dead cells, and samples were analyzedconcentration of one cell per well in 20 l of serum-free medium
(all groups in survival experiment and proB cell cultures) or serum- on a FACSCalibur.
containing medium (for evaluation of in vitro myeloid potential only)
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pled to the FACSVantage (giving similar results). In some experi-
ments, single cells were verified by microscopy 2–12 hr after seed- The authors thank Dr. Corrado Cilio and Karin Petersson for expert
ing, and only wells containing one cell were included in the advice and assistance in intrathymic injections, Dr. Kris Grzegorzew-
experiments. The serum-free medium (X-vivo 15; BioWhittaker) was ski for expert evaluation of cellular morphology, and Per Anders
supplemented with 1% detoxified Bovine Serum Albumin (BSA; Bertilsson, Sverker Segren, Carl-Magnus Ho¨gerkorp, and Anna Fos-
Stem Cell Technologies Inc). A serum-containing medium (IMDM; sum for essential assistance in cell sorting. The technical assistance
BioWhittaker), was supplemented with 20% FCS. Wells were scored of Gunilla Ga¨rdebring, Eva Gynnstam, Irene Persson, and Lilian Witt-
for cell growth following 10–14 days of culture. Individual colonies man is also highly appreciated. We thank Graham Molineux (Amgen)
were transferred to slides in a cytospin centrifuge and examined and Stewart Lyman (Immunex) for generously contributing cytokines
morphologically after May-Gru¨nwald/Giemsa-staining or were for these studies, Dr. William Matthews (Genentech) for providing
stained with antibodies and analyzed by flow cytometry. anti-flt3 antibodies, and in particular Dr. Koichi Akashi for fruitful
discussions and for sharing important reagents for these studies.
These studies were generously supported by grants from: ALFIn Vivo Reconstitution Experiments
All mice experiments were approved by the local ethics committee. (Government Public Health Grant); the Berta Kamprad Foundation;
the Crafoord Foundation; the Harald and Greta Jeansson Founda-500–1000 LSKflt3, LSKflt3, or LSK freshly isolated Ly5.1 cells or
their cultured equivalents were injected intravenously to lethally tion; the Thelma Zoega Foundation; the John and Augusta Persson
Foundations; the Medical Faculty, University of Lund; The Swedishirradiated (950 rad) C57Bl/6 (Ly5.2) mice. All mice were kept in indi-
vidually ventilated cages throughout the experiment and given ster- Medical Research Council (MFR); the Svensson Siblings Founda-
Immunity
668
tion; the O.E. and Edla Johansson Foundation; the Royal Physio- Li, C.L., and Johnson, G.R. (1995). Murine hematopoietic stem and
progenitor cells: I. Enrichment and biologic characterization. Bloodgraphic Society in Lund, and the Swedish Foundation for Strategic
Research. 85, 1472–1479.
Lyman, S.D., and Jacobsen, S.E. (1998). c-kit ligand and Flt3 ligand:
Received February 21, 2001; revised August 17, 2001. stem/progenitor cell factors with overlapping yet distinct activities.
Blood 91, 1101–1134.
References Mackarehtschian, K., Hardin, J.D., Moore, K.A., Boast, S., Goff, S.P.,
and Lemischka, I.R. (1995). Targeted disruption of the flk2/flt3 gene
Alexander, W.S., Roberts, A.W., Nicola, N.A., Li, R., and Metcalf, D. leads to deficiencies in primitive hematopoietic progenitors. Immu-
(1996). Deficiencies in progenitor cells of multiple hematopoietic nity 3, 147–161.
lineages and defective megakaryocytopoiesis in mice lacking the Matsunaga, T., Kato, T., Miyazaki, H., and Ogawa, M. (1998). Throm-
thrombopoietic receptor c-Mpl. Blood 87, 2162–2170. bopoietin promotes the survival of murine hematopoietic long-term
Bodine, D.M., Orlic, D., Birkett, N.C., Seidel, N.E., and Zsebo, K.M. reconstituting cells: comparison with the effects of FLT3/FLK-2
(1992). Stem cell factor increases colony-forming unit-spleen num- ligand and interleukin-6. Blood 92, 452–461.
ber in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice Matthews, W., Jordan, C.T., Wiegand, G.W., Pardoll, D., and Lem-
as a single factor. Blood 79, 913–919. ischka, I.R. (1991). A receptor tyrosine kinase specific to hematopoi-
Borge, O.J., Adolfsson, J., and Jacobsen, A.M. (1999). Lymphoid- etic stem and progenitor cell-enriched populations. Cell 65, 1143–
restricted development from multipotent candidate murine stem 1152.
cells: distinct and complimentary functions of the c-kit and flt3- McKenna, H.J., Stocking, K.L., Miller, R.E., Brasel, K., De Smedt,
ligands. Blood 94, 3781–3790. T., Maraskovsky, E., Maliszewski, C.R., Lynch, D.H., Smith, J., Pulen-
Brady, G., Barbara, M., and Iscove, N. (1990). Representative in dran, B., et al. (2000). Mice lacking flt3 ligand have deficient hemato-
vitro cDNA amplification from individual hematopoietic cells and poiesis affecting hematopoietic progenitor cells, dendritic cells, and
colonies. Methods Mol. Cell. Biol. 2, 17–25. natural killer cells. Blood 95, 3489–3497.
Metcalf, D. (1993). Hematopoietic regulators: redundancy or sub-Bryder, D., and Jacobsen, S.E. (2000). Interleukin-3 supports expan-
sion of long-term multilineage repopulating activity after multiple tlety? Blood 82, 3515–3523.
stem cell divisions in vitro. Blood 96, 1748–1755. Miller, C.L., and Eaves, C.J. (1997). Expansion in vitro of adult murine
hematopoietic stem cells with transplantable lympho-myeloid re-Dao, M.A., Hannum, C.H., Kohn, D.B., and Nolta, J.A. (1997). FLT3
constituting ability. Proc. Natl. Acad. Sci. USA 94, 13648–13653.ligand preserves the ability of human CD34 progenitors to sustain
long-term hematopoiesis in immune-deficient mice after ex vivo Miller, C.L., Rebel, V.I., Lemieux, M.E., Helgason, C.D., Lansdorp,
retroviral-mediated transduction. Blood 89, 446–456. P.M., and Eaves, C.J. (1996). Studies of W mutant mice provide
evidence for alternate mechanisms capable of activating hemato-Domen, J., and Weissman, I.L. (1999). Self-renewal, differentiation
poietic stem cells. Exp. Hematol. 24, 185–194.or death: regulation and manipulation of hematopoietic stem cell
fate. Mol. Med. Today 5, 201–208. Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulat-
ing subset of hematopoietic stem cells is deterministic and isolat-Domen, J., Cheshier, S.H., and Weissman, I.L. (2000). The role of
able by phenotype. Immunity 1, 661–673.apoptosis in the regulation of hematopoietic stem cells. Overexpres-
sion of bcl-2 increases both their number and repopulation potential. Okada, S., Nakauchi, H., Nagayoshi, K., Nishikawa, S., Miura, Y.,
J. Exp. Med. 191, 253–264. and Suda, T. (1991). Enrichment and characterization of murine he-
matopoietic stem cells that express c-kit molecule. Blood 78, 1706–Elwood, N.J., Zogos, H., Willson, T., and Begley, C.G. (1996). Retrovi-
1712.ral transduction of human progenitor cells: use of granulocyte col-
ony-stimulating factor plus stem cell factor to mobilize progenitor Orlic, D., Fischer, R., Nishikawa, S., Nienhuis, A.W., and Bodine,
cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood 88, D.M. (1993). Purification and characterization of heterogeneous plu-
4452–4462. ripotent hematopoietic stem cell populations expressing high levels
of c-kit receptor. Blood 82, 762–770.Geissler, E.N., and Russell, E.S. (1983). Analysis of the hematopoietic
effects of new dominant spotting (W) mutations of the mouse. Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Long-
I. Influence upon hematopoietic stem cells. Exp. Hematol. 11, term lymphohematopoietic reconstitution by a single CD34-low/
452–460. negative hematopoietic stem cell. Science 273, 242–245.
Goldschneider, I., Komschlies, K.L., and Greiner, D.L. (1986). Studies Petzer, A.L., Zandstra, P.W., Piret, J.M., and Eaves, C.J. (1996).
of thymocytopoiesis in rats and mice. I. Kinetics of appearance of Differential cytokine effects on primitive (CD34CD38-) human he-
thymocytes using a direct intrathymic adoptive transfer assay for matopoietic cells: novel responses to Flt3-ligand and thrombopoie-
thymocyte precursors. J. Exp. Med. 163, 1–17. tin. J. Exp. Med. 183, 2551–2558.
Hsu, H.C., Ema, H., Osawa, M., Nakamura, Y., Suda, T., and Naka- Piacibello, W., Sanavio, F., Garetto, L., Severino, A., Bergandi, D.,
uchi, H. (2000). Hematopoietic stem cells express tie-2 receptor in Ferrario, J., Fagioli, F., Berger, M., and Aglietta, M. (1997). Extensive
the murine fetal liver. Blood 96, 3757–3762. amplification and self-renewal of human primitive hematopoietic
stem cells from cord blood. Blood 89, 2644–2653.Ikuta, K., and Weissman, I.L. (1992). Evidence that hematopoietic
stem cells express mouse c-kit but do not depend on steel factor Randall, T.D., Lund, F.E., Howard, M.C., and Weissman, I.L. (1996).
for their generation. Proc. Natl. Acad. Sci. USA 89, 1502–1506. Expression of murine CD38 defines a population of long-term recon-
stituting hematopoietic stem cells. Blood 87, 4057–4067.Keller, J.R., Ortiz, M., and Ruscetti, F.W. (1995). Steel factor (c-kit
ligand) promotes the survival of hematopoietic stem/progenitor cells Sato, T., Laver, J.H., and Ogawa, M. (1999). Reversible expression
in the absence of cell division. Blood 86, 1757–1764. of CD34 by murine hematopoietic stem cells. Blood 94, 2548–2554.
Kimura, S., Roberts, A.W., Metcalf, D., and Alexander, W.S. (1998). Solar, G.P., Kerr, W.G., Zeigler, F.C., Hess, D., Donahue, C., de
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the Sauvage, F.J., and Eaton, D.L. (1998). Role of c-mpl in early hemato-
receptor for thrombopoietin. Proc. Natl. Acad. Sci. USA 95, 1195– poiesis. Blood 92, 4–10.
1200. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purifica-
Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of tion and characterization of mouse hematopoietic stem. Science
clonogenic common lymphoid progenitors in mouse bone marrow. 241, 58–62.
Cell 91, 661–672. Theilgaard-Monch, K., Cowland, J., and Borregaard, N. (2001). Pro-
filing of gene expression in individual hematopoietic cells by globalLi, C.L., and Johnson, G.R. (1994). Stem cell factor enhances the
survival but not the self-renewal of murine hematopoietic long-term mRNA amplification and slot blot analysis. J. Immunol. Methods
252, 175–189.repopulating cells. Blood 84, 408–414.
Flt3 Stem Cells Reconstitute Lymphopoiesis
669
Veiby, O.P., Jacobsen, F.W., Cui, L., Lyman, S.D., and Jacobsen,
S.E. (1996). The flt3 ligand promotes the survival of primitive hemo-
poietic progenitor cells with myeloid as well as B lymphoid potential.
Suppression of apoptosis and counteraction by TNF-alpha and
TGF-beta. J. Immunol. 157, 2953–2960.
Veiby, O.P., Borge, O.J., Martensson, A., Beck, E.X., Schade, A.E.,
Grzegorzewski, K., Lyman, S.D., Martensson, I.L., and Jacobsen,
S.E. (1997). Bidirectional effect of interleukin-10 on early murine
B-cell development: stimulation of flt3-ligand plus interleukin-7-
dependent generation of CD19() ProB cells from uncommitted
bone marrow progenitor cells and growth inhibition of CD19() ProB
cells. Blood 90, 4321–4331.
Yonemura, Y., Ku, H., Lyman, S.D., and Ogawa, M. (1997). In vitro
expansion of hematopoietic progenitors and maintenance of stem
cells: comparison between FLT3/FLK-2 ligand and KIT ligand. Blood
89, 1915–1921.
Zeigler, F.C., Bennett, B.D., Jordan, C.T., Spencer, S.D., Baum-
hueter, S., Carroll, K.J., Hooley, J., Bauer, K., and Matthews,
W. (1994). Cellular and molecular characterization of the role of the
flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells.
Blood 84, 2422–2430.
Zhang, S., Fukuda, S., Lee, Y., Hangoc, G., Cooper, S., Spolski, R.,
Leonard, W.J., and Broxmeyer, H.E. (2000). Essential role of signal
transducer and activator of transcription (Stat)5a but not Stat5b for
Flt3-dependent signaling. J. Exp. Med. 192, 719–728.
